Clinical trials
Phase 3 Pneumonia, Bacterial trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 2 |
| 2012 | 3 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Terminated | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wyeth is now a wholly owned subsidiary of Pfizer | 3 |
| Bayer | 2 |
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2 |
| Cumberland Pharmaceuticals | 2 |
| Forest Laboratories | 2 |
| Paratek Pharmaceuticals Inc | 2 |
| Albany Medical College | 1 |
| Biotest | 1 |
| Hospitales Universitarios Virgen del Rocío | 1 |
| Janssen Research & Development, LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pneumonia, Bacterial | 25 |
| Community-Acquired Pneumonia | 10 |
| Pneumonia | 6 |
| Cross Infection | 4 |
| Healthcare-Associated Pneumonia | 4 |
| Pneumonia, Ventilator-Associated | 4 |
| Community-Acquired Infections | 3 |
| Haemophilus Infections | 2 |
| Pneumonia, Viral | 2 |
| COVID-19 | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.